Human immunodeficiency virus-associated vitiligo: expression of autoimmunity with immunodeficiency?
- PMID: 3668011
- PMCID: PMC7134483
- DOI: 10.1016/s0190-9622(87)70252-7
Human immunodeficiency virus-associated vitiligo: expression of autoimmunity with immunodeficiency?
Abstract
Persistent viral infections have been postulated to be trigger factors for the development of autoimmune disease. We report the development of vitiligo in four patients with human immunodeficiency virus (HIV)-related conditions and in one patient with hepatitis who later developed both psoriasis and acquired immunodeficiency syndrome (AIDS). Other common features were hepatitis and multiple other viral infections. Ribavirin was associated with repigmentation in one patient. Vitiligo may be an example of an autoimmune disease triggered by viral infection in a genetically predisposed host.
References
-
- Lerner AB, Nordlund JJ. Vitiligo; what is it? Is it important? J Am Med Assoc. 1978;239:1183–1187. - PubMed
-
- Nordlund JJ. In: Pathogenesis of skin disease. Thiers BH, Dobson RL, editors. Churchill Livingstone; New York: 1986. Vitiligo; pp. 99–127.
-
- Lucky PA, Nordlund JJ. The biology of the pigmentary system and its disorders. Dermatol Clinic. 1985;3:197–216. - PubMed
-
- Dawber RPR, Bleehan SS, Vallance-Owen J. Vitiligo and diabetes mellitus. Br J Dermatol. 1977;84:600. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
